Question 1

What are the potential side effects of GS-9674 compared to the placebo?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH) clinical trial (NCT02854605). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my liver function be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH) clinical trial (NCT02854605). Contact the study team or your healthcare provider for specific answers.

Question 3

What happens if I experience side effects while participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH) clinical trial (NCT02854605). Contact the study team or your healthcare provider for specific answers.

Question 4

How does this treatment compare to my current options for managing NASH?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH) clinical trial (NCT02854605). Contact the study team or your healthcare provider for specific answers.

Question 5

What is the expected duration of my participation in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH) clinical trial (NCT02854605). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any travel requirements for attending study visits?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH) clinical trial (NCT02854605). Contact the study team or your healthcare provider for specific answers.

What this study is about